Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CEACAM1 based point-of-care cancer diagnostic

CEACAM1 based point-of-care cancer diagnostic

US Patent 12130287 · Granted Oct 29, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CEACAM based antibacterial agents2024
Wearable items providing physiological, environmental and situational parameter 2024
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)2024
Humanized antibodies against CEACAM12024
Modulation of immunity and CEACAM1 activity2023
CEACAM based antibacterial agents2022
Polynucleotides encoding humanized antibodies against CEACAM12022
Mobile communication device and other devices with cardiovascular monitoring cap2022
Wearable items providing physiological, environmental and situational parameter 2021
CEACAM based antibacterial agents2020
CEACAM1 based point-of-care cancer diagnostic2020
Humanized antibodies against CEACAM12020